SCHEMBL29671561

SCHEMBL29671561

COC(=O)[C@H]1CCCCN1c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 3/20 0.47
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
OPRK1 P41145 1/20 0.45
OGFRL1 Q5TC84 1/20 0.45
SCN9A Q15858 1/20 0.45
LTA4H P09960 2/20 0.44
BACE1 P56817 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 1/20 0.44
SLC6A4 P31645 2/20 0.43
MMP2 P08253 1/20 0.43
ANPEP P15144 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ALOX5 P09917 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27551310 1.00 FKBP1A (0.47) FKBP1AOPRM1OPRD1OPRK1OGFRL1
SCHEMBL26246339 0.95 SCN9A (0.48) FKBP1AOPRM1OPRD1OPRK1OGFRL1
SCHEMBL29035348 0.95 SCN9A (0.48) FKBP1AOPRM1OPRD1OPRK1OGFRL1
Hydrochloric Acid SCHEMBL29289926 0.94 SCN9A (0.47) FKBP1AOPRM1OPRD1OPRK1OGFRL1
SCHEMBL29671593 0.89 KMT2A (0.47) FKBP1ALTA4HSMN1; SMN2KMT2ASLC6A4
SCHEMBL2770443 0.89 KMT2A (0.47) FKBP1ALTA4HSMN1; SMN2KMT2ASLC6A4
SCHEMBL29349017 0.87 ALDH1A1 (0.46) FKBP1ABACE1KMT2AMMP2ANPEP
SCHEMBL29349018 0.85 ALDH1A1 (0.44) FKBP1AOPRM1OPRD1OPRK1OGFRL1
SCHEMBL29349019 0.85 SLC6A3 (0.44) FKBP1AOPRM1OPRD1OPRK1OGFRL1
SCHEMBL8095933 0.84 MEN1 (0.54) FKBP1ASMN1; SMN2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3930849-B1 THIAZOLE DERIVATIVES AS PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2025-02-19 EP disclosed
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G FKBP1A 1409/4885OPRM1 4412/4885OPRD1 4228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.